ArticleThe Journal of surgical research2026
The Association Between Insurance Type and Financial Toxicity in Older Adult Surgical Patients.
Article in The Journal of surgical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionSurgical patients often face significant financial strain, termed financial toxicity (FT). Among US adults aged ≥65 years, insurance options include public (Medicare), subsidized private (Medicare Advantage [MA]), and private insurance. We examined FT by insurance coverage in this population.
methodsWe analyzed adults ≥65 years with Medicare, MA, or private insurance who underwent inpatient surgery in the Medical Expenditure Panel Survey (2017-2022). FT was defined as difficulty paying medical bills, delaying or skipping medications, or postponing care due to cost. Secondary outcomes included annual out-of-pocket (OOP) costs and total health-care expenditure (THE; OOP plus premiums). Logistic and linear regression models estimated adjusted odds of FT, OOP costs, and THE by insurance type.
resultsAmong 4089 patients (weighted n = 6.7 million), 21.9% reported FT: 24.6% Medicare, 23.2% MA, and 19.2% private (P = 0.047). The mean OOP costs were $2395 ($2451 Medicare, $2291 MA, and $2452 private; P = 0.72). THE averaged $9243 ($6071 Medicare, $7824 MA, $9975 private; P < 0.001). Compared with Medicare, adjusted odds of FT were similar for MA (odds ratio 1.07, 95% confidence interval [CI] 0.79-1.42) and private insurance (odds ratio 0.89, 95% CI 0.64-1.23). THE was higher for MA (+$1,823, 95% CI $114-$3533) and private insurance (+$3,842, 95% CI $2170-$5513).
conclusionsDespite subsidized insurance, FT remains prevalent among older adult surgical patients. Private and MA plans incur higher total costs than Medicare plans without lowering FT risk. As MA enrollment rises, we must work to understand the driving factors behind patient insurance plan selection and work to optimize it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.